US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CG Oncology Inc.

25.55

-0.7300-2.78%

Post-market: 25.550.0020+0.01%17:01 EDT

Volume:987.48K

Turnover:25.34M

Market Cap:1.95B

PE:-16.89

High:26.46

Open:26.45

Low:25.43

Close:26.28

Loading ...

Overview Company News Filings

CG Oncology Files Mixed Shelf

MT Newswires Live

CG Oncology Full Year 2024 Earnings: Misses Expectations

Simply Wall St.

CG Oncology Advances in Bladder Cancer Therapeutics

CG Oncology files automatic mixed securities shelf

BRIEF-CG Oncology Inc Files For Mixed Shelf Offering Size Not Disclosed- SEC Filing

Promising Clinical Data and Strong Financials Support Buy Rating for CG Oncology

BRIEF-CG Oncology Reports 2024 Year End Financial Results And Provides Business Updates

CG Oncology Inc: Qtrly Shr Loss $0.46

THOMSON REUTERS

Press Release: CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates

CG Oncology Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

Buy Rating for CG Oncology: Promising Phase 3 Results and Strong Safety Profile of Cretostimogene

CG Oncology Shares Rise After Reporting Bladder Cancer Drug Durability in Phase 3 Trial

MT Newswires Live

Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as Well as Consistent and Compelling Safety and Efficacy

THOMSON REUTERS

CG Oncology Inc -Median Duration of Response Exceeds 28 Months and Is Ongoing

THOMSON REUTERS

CG Oncology Inc - Announces 75.5% Complete Response Rate in Phase 3 Study

THOMSON REUTERS

Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy

CG Oncology Coverage Assumed by Morgan Stanley at Overweight

Buy Rating for CG Oncology: Promising Market Position and Upside Potential of Cretostimogene in NMIBC Treatment

CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference

Is CG Oncology, Inc. (CGON) An Oversold Biotech Stock to Buy Now?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CGON/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CGON","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGON\",,,,,undefined,":{"symbol":"CGON","market":"US","secType":"STK","nameCN":"CG Oncology Inc.","latestPrice":25.55,"timestamp":1750449600000,"preClose":26.28,"halted":0,"volume":987475,"hourTrading":{"tag":"盘后","latestPrice":25.55,"preClose":25.548,"latestTime":"17:01 EDT","volume":213998,"amount":5467648.2072,"timestamp":1750453260446},"delay":0,"floatShares":61126461,"shares":76225308,"eps":-1.512766,"marketStatus":"Not Yet Opened","change":-0.73,"latestTime":"06-20 16:00:00 EDT","open":26.45,"high":26.46,"low":25.43,"amount":25344395.1035,"amplitude":0.039193,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.512766,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":0,"adr":0,"listingDate":1706158800000,"exchange":"NASDAQ","adjPreClose":26.28,"preHourTrading":{"tag":"盘前","latestPrice":26.3,"preClose":26.28,"latestTime":"09:27 EDT","volume":880,"amount":23167.70104,"timestamp":1750426060083},"postHourTrading":{"tag":"盘后","latestPrice":25.55,"preClose":25.548,"latestTime":"17:01 EDT","volume":213998,"amount":5467648.2072,"timestamp":1750453260446},"volumeRatio":1.12153057934611,"optionData":{"bulkOrders":[{"symbol":"CGON","call":true,"expireDate":1750392000000,"strike":"25.0","timestamp":1750437161888,"price":1.01,"volume":3000,"amount":303000,"type":"-"},{"symbol":"CGON","call":true,"expireDate":1752811200000,"strike":"25.0","timestamp":1750437161888,"price":2.06,"volume":3000,"amount":618000,"type":"-"}]},"impliedVol":0.6456,"impliedVolPercentile":0.424},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGON\",,,,,undefined,":{"symbol":"CGON","floatShares":61126461,"roa":"-12.85%","roe":"-16.57%","lyrEps":-1.408697,"volumeRatio":1.12153057934611,"shares":76225308,"dividePrice":0,"high":26.46,"amplitude":0.039193,"preClose":26.28,"low":25.43,"week52Low":14.8,"pbRate":"2.76","psRate":"2941.93","week52High":40.47,"institutionHeld":0,"latestPrice":25.55,"eps":-1.512766,"divideRate":0,"volume":987475,"delay":0,"ttmEps":-1.512766,"open":26.45,"prevYearClose":28.68,"prevWeekClose":25.86,"prevMonthClose":25.62,"prevQuarterClose":24.49,"fiveDayClose":26.5,"twentyDayClose":26.22,"sixtyDayClose":27.54},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CGON\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2523960794","title":"CG Oncology Files Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2523960794","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523960794?lang=en_us&edition=fundamental","pubTime":"2025-03-31 16:09","pubTimestamp":1743408566,"startTime":"0","endTime":"0","summary":"CG Oncology  filed a registration statement Friday for the potential sale of an unspecified amount of securities from time to time.The filing covers the sale of the company's common stock, preferred stock, debt securities and warrants.The company aims to use the proceeds from the offering for general corporate purposes.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4135","CGON","CG","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4139"],"gpt_icon":0},{"id":"2523611209","title":"CG Oncology Full Year 2024 Earnings: Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2523611209","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523611209?lang=en_us&edition=fundamental","pubTime":"2025-03-29 21:48","pubTimestamp":1743256108,"startTime":"0","endTime":"0","summary":"CG Oncology ( NASDAQ:CGON ) Full Year 2024 Results Key Financial Results Net loss: US$88.0m (loss widened by 30% from...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/cg-oncology-full-year-2024-earnings-misses-expectations","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CGON","CG"],"gpt_icon":0},{"id":"2523566341","title":"CG Oncology Advances in Bladder Cancer Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2523566341","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523566341?lang=en_us&edition=fundamental","pubTime":"2025-03-29 12:03","pubTimestamp":1743221013,"startTime":"0","endTime":"0","summary":"CG Oncology, Inc. ( ($CGON) ) has released its Q4 earnings. Here is a breakdown of the information CG Oncology, Inc. presented to its investors. CG...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cg-oncology-advances-in-bladder-cancer-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cg-oncology-advances-in-bladder-cancer-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IE00B3QW5Z07.USD","BK4135","CG","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LENZ","CGON"],"gpt_icon":0},{"id":"2523495636","title":"CG Oncology files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2523495636","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523495636?lang=en_us&edition=fundamental","pubTime":"2025-03-29 05:06","pubTimestamp":1743195979,"startTime":"0","endTime":"0","summary":"17:00 EDT CG Oncology (CGON) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cg-oncology-files-automatic-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cg-oncology-files-automatic-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B3QW5Z07.USD","CGON","CG","IE00BGHQF748.EUR","BK4135","BK4139","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2523626635","title":"BRIEF-CG Oncology Inc  Files For Mixed Shelf Offering Size Not Disclosed- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2523626635","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523626635?lang=en_us&edition=fundamental","pubTime":"2025-03-29 05:00","pubTimestamp":1743195624,"startTime":"0","endTime":"0","summary":"BRIEF-CG Oncology Inc  Files For Mixed Shelf Offering Size Not Disclosed- SEC FilingMarch 28  - CG Oncology Inc CGON.O:CG ONCOLOGY INC:  FILES FOR MIXED SHELF OFFERING; SIZE NOT DISCLOSED- SEC FILINGSource text: [ID:n0001193125-25-067207]Further company coverage: CGON.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QB1HB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2523682236","title":"Promising Clinical Data and Strong Financials Support Buy Rating for CG Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2523682236","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523682236?lang=en_us&edition=fundamental","pubTime":"2025-03-29 03:15","pubTimestamp":1743189309,"startTime":"0","endTime":"0","summary":"Analyst Sam Slutsky from LifeSci Capital maintained a Buy rating on CG Oncology, Inc. (CGON – Research Report) and decreased the price target to $8...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-clinical-data-and-strong-financials-support-buy-rating-for-cg-oncology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-clinical-data-and-strong-financials-support-buy-rating-for-cg-oncology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CG","CGON"],"gpt_icon":0},{"id":"2522782005","title":"BRIEF-CG Oncology Reports 2024 Year End Financial Results And Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522782005","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522782005?lang=en_us&edition=fundamental","pubTime":"2025-03-28 19:52","pubTimestamp":1743162750,"startTime":"0","endTime":"0","summary":"BRIEF-CG Oncology Reports 2024 Year End Financial Results And Provides Business UpdatesMarch 28 (Reuters) - CG Oncology Inc CGON.O:CG ONCOLOGY REPORTS 2024 YEAR END FINANCIAL RESULTS AND PROVIDES BUSI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nTUA4MT7GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2522612522","title":"CG Oncology Inc: Qtrly Shr Loss $0.46","url":"https://stock-news.laohu8.com/highlight/detail?id=2522612522","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522612522?lang=en_us&edition=fundamental","pubTime":"2025-03-28 19:00","pubTimestamp":1743159601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nTUA4MT7GL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2522430524","title":"Press Release: CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522430524","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522430524?lang=en_us&edition=fundamental","pubTime":"2025-03-28 19:00","pubTimestamp":1743159600,"startTime":"0","endTime":"0","summary":"- Cretostimogene Monotherapy Demonstrated Sustained, Durable Complete Responses in High-Risk Bacillus Calmette Guérin -Unresponsive Non-Muscle Invasive Bladder Cancer  -. - Initiated CORE-008 Clinical Trial of Cretostimogene Monotherapy in High-Risk BCG-Nave  and BCG-Exposed  NMIBC -. - Late-Breaking Clinical and First Translational Data from BOND-003 Cohort C Presented at the 40th Annual European Association of Urology Congress -. IRVINE, Calif., March 28, 2025  -- CG Oncology, Inc. , a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today reported financial results for the fourth quarter and year ended December 31, 2024, and provided business updates.Any Time in High-Risk  BCG-Unresponsive NMIBC with carcinoma in situ. reached but exceeds 28 months as of the data cutoff of Januar","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BGHQF748.EUR","CI","BCG","BK4161","IE00BSNM7G36.USD","LU0058720904.USD","LU0289739699.SGD","US6M.BOND","BK4135","US7Y.BOND","BK4585","BK4139","HR","US30Y.BOND","BK4196","BK4203","US3Y.BOND","CR","LU1059921491.USD","US2Y.BOND","IE00B19Z3581.USD","BK4588","US10Y.BOND","IE0002270589.USD","CGON","US12M.BOND","US5Y.BOND","IE00B19Z3B42.SGD","BK4225","LU1261432733.SGD","CG","LU0868494617.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2522304051","title":"CG Oncology Price Target Maintained With a $75.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2522304051","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522304051?lang=en_us&edition=fundamental","pubTime":"2025-03-25 18:51","pubTimestamp":1742899860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2025 06:51 ET (10:51 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","CG"],"gpt_icon":0},{"id":"2522044344","title":"Buy Rating for CG Oncology: Promising Phase 3 Results and Strong Safety Profile of Cretostimogene","url":"https://stock-news.laohu8.com/highlight/detail?id=2522044344","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522044344?lang=en_us&edition=fundamental","pubTime":"2025-03-25 18:16","pubTimestamp":1742897764,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Andres Y. Maldonado maintained a Buy rating on CG Oncology, Inc. (CGON – Research Report) today and set a price target of $...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-cg-oncology-promising-phase-3-results-and-strong-safety-profile-of-cretostimogene?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-cg-oncology-promising-phase-3-results-and-strong-safety-profile-of-cretostimogene?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CG","CGON"],"gpt_icon":0},{"id":"2522777826","title":"CG Oncology Shares Rise After Reporting Bladder Cancer Drug Durability in Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2522777826","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522777826?lang=en_us&edition=fundamental","pubTime":"2025-03-25 00:36","pubTimestamp":1742834172,"startTime":"0","endTime":"0","summary":"CG Oncology  rose over 4% on Monday after the company said roughly 76% of patients in a phase 3 trial of cretostimogene for high-risk bladder cancer showed a complete response at some point.As of Jan. 20, 46% of patients remained in complete response at 12 months, with 30 confirmed responses at 24 months.The study evaluated cretostimogene monotherapy for high-risk Bacillus Calmette Guerin-unresponsive non-muscle invasive bladder cancer with carcinoma in situ. Data show that 83 out of 110 patients in the trial achieved complete response at some point.Data also showed that cretostimogene levels peaked immediately after administration and lasted locally for 4 to 5 days. There was no systemic exposure reported.These results were presented at the recent annual European Association of Urology Congress in Madrid, Spain.Price: 28.26, Change: +1.21, Percent Change: +4.47","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CG","CGON","BK4139","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4135","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2521742270","title":"Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as Well as Consistent and Compelling Safety and Efficacy","url":"https://stock-news.laohu8.com/highlight/detail?id=2521742270","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521742270?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:00","pubTimestamp":1742817602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nTUA9KM6Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2521479537","title":"CG Oncology Inc -Median Duration of Response Exceeds 28 Months and Is Ongoing","url":"https://stock-news.laohu8.com/highlight/detail?id=2521479537","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521479537?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:00","pubTimestamp":1742817602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nTUA9KM6Z0:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2521374764","title":"CG Oncology Inc - Announces 75.5% Complete Response Rate in Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2521374764","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521374764?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:00","pubTimestamp":1742817602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nTUA9KM6Z0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2521747112","title":"Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy","url":"https://stock-news.laohu8.com/highlight/detail?id=2521747112","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521747112?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:00","pubTimestamp":1742817600,"startTime":"0","endTime":"0","summary":"– Latest BOND-003 data show 75.5% of patients achieved a complete response at any time –– Median duration of response exceeds 28 months and is ongoing –– No close contact precautions needed post creto","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/24/3047782/0/en/Cretostimogene-Grenadenorepvec-Data-Continues-to-Demonstrate-Best-in-Class-Durability-of-Response-as-well-as-Consistent-and-Compelling-Safety-and-Efficacy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4135","CR","BCG","BK4161","CGON"],"gpt_icon":0},{"id":"2517251456","title":"CG Oncology Coverage Assumed by Morgan Stanley at Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2517251456","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517251456?lang=en_us&edition=fundamental","pubTime":"2025-03-08 01:27","pubTimestamp":1741368420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 07, 2025 12:27 ET (17:27 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","CG"],"gpt_icon":0},{"id":"2517484575","title":"Buy Rating for CG Oncology: Promising Market Position and Upside Potential of Cretostimogene in NMIBC Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2517484575","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517484575?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:19","pubTimestamp":1741349994,"startTime":"0","endTime":"0","summary":"CG Oncology, Inc. (CGON) has received a new Buy rating, initiated by Morgan Stanley analyst, Sean Laaman. Sean Laaman’s rating is based on the prom...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-cg-oncology-promising-market-position-and-upside-potential-of-cretostimogene-in-nmibc-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-cg-oncology-promising-market-position-and-upside-potential-of-cretostimogene-in-nmibc-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","CG"],"gpt_icon":0},{"id":"2514837053","title":"CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2514837053","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514837053?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:00","pubTimestamp":1740574800,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Feb.  26, 2025  (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bla","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/26/3032854/0/en/CG-Oncology-to-Present-at-the-TD-Cowen-45th-Annual-Health-Care-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TD","BK4139","CGON","BK4207","IE00B64PRP62.GBP","BK4566","CG","IE00B3QW5Z07.USD","BK4585","IE00BGHQF748.EUR","BK4135","BK4127","COWN"],"gpt_icon":0},{"id":"2514018475","title":"Is CG Oncology, Inc. (CGON) An Oversold Biotech Stock to Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514018475","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514018475?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:49","pubTimestamp":1740494963,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Oversold Biotech Stocks to Buy Now. In this article, we are going to take a look at where CG Oncology, Inc.  stands against the other oversold biotech stocks to buy now.Goldman Sachs clarified biotech as a frequently disregarded area of the investment world. John Flood, Head of Americas Equities Sales Trading at Goldman, wrote in a letter to clients that biotech equities offered an unnoticed opportunity for investors hoping to profit from the Fed’s recent rate decreases. Because biotech equities are sensitive to interest rate changes and frequently depend on anticipated future revenues, they are particularly impacted. The cost of capital has a significant effect on these equities as well. These equities have substantial upsid","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cg-oncology-inc-cgon-oversold-144923366.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","US30Y.BOND","NVIW.SI","QLD","BK4139","CAGR","US10Y.BOND","SQQQ","CGON","IE00BGHQF748.EUR","US12M.BOND","TQQQ","BK4150","IE00B3QW5Z07.USD","TSYW.SI","USJW.SI","NQmain","BK4135","BK4159",".IXIC","MNQmain","US5Y.BOND","FOMC","US7Y.BOND","RSI","USAW.SI","BK4077","IE00B64PRP62.GBP","US2Y.BOND","CG","US6M.BOND","US3Y.BOND","QID"],"gpt_icon":1}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":94,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CGON\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"CGON","fiscalQuarterEnding":"2025/03","expectedEps":-0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-03-28","symbol":"CGON","fiscalQuarterEnding":"2024/12","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743134400000,"reportTimeType":"pre","actualEps":-0.48},{"market":"US","date":"2024-11-12","symbol":"CGON","fiscalQuarterEnding":"2024/09","expectedEps":-0.42,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CGON\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CGON\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1,"buy":0.8,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":10,"updateTime":1746244800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CGON\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CGON","date":"2025-06-20","current":-18.977435,"percent":0.903614,"low":-77.942097,"twenty":-49.032283,"median":-37.168124,"eighty":-26.449487,"high":-13.496527,"avg":-38.172694,"sd":14.718632,"marketCap":2003201094},"quantilePoints":[{"date":"2024-01-26","current":-62.124194,"twenty":-62.124194,"median":-62.124194,"eighty":-62.124194,"marketCap":2539823423},{"date":"2024-02-02","current":-61.712969,"twenty":-61.712969,"median":-60.379514,"eighty":-59.355029,"marketCap":2523011292},{"date":"2024-02-09","current":-63.452965,"twenty":-62.124194,"median":-60.590915,"eighty":-59.355029,"marketCap":2594147579},{"date":"2024-02-16","current":-77.177799,"twenty":-70.608092,"median":-61.918582,"eighty":-60.168112,"marketCap":3155259972},{"date":"2024-02-23","current":-75.080046,"twenty":-72.448911,"median":-64.672589,"eighty":-60.20714,"marketCap":3069497532},{"date":"2024-03-01","current":-72.705845,"twenty":-73.870179,"median":-70.608092,"eighty":-60.516111,"marketCap":2972433066},{"date":"2024-03-08","current":-64.818944,"twenty":-72.891228,"median":-69.827533,"eighty":-60.799064,"marketCap":2649992888},{"date":"2024-03-15","current":-60.493345,"twenty":-72.302556,"median":-67.469593,"eighty":-60.20714,"marketCap":2473149409},{"date":"2024-03-22","current":-66.867912,"twenty":-72.162706,"median":-65.355579,"eighty":-60.438055,"marketCap":2733760852},{"date":"2024-03-28","current":-56.207672,"twenty":-71.967566,"median":-64.762028,"eighty":-59.842879,"marketCap":2732086332},{"date":"2024-04-05","current":-51.752186,"twenty":-71.648838,"median":-63.50175,"eighty":-58.14191,"marketCap":2515518513},{"date":"2024-04-12","current":-54.631116,"twenty":-71.284577,"median":-62.382039,"eighty":-56.136384,"marketCap":2655454642},{"date":"2024-04-19","current":-48.420853,"twenty":-71.001624,"median":-61.712969,"eighty":-54.576279,"marketCap":2353592420},{"date":"2024-04-26","current":-49.627262,"twenty":-70.73168,"median":-60.54213,"eighty":-53.208102,"marketCap":2412232322},{"date":"2024-05-03","current":-54.151294,"twenty":-70.286112,"median":-60.183337,"eighty":-53.600185,"marketCap":2632131954},{"date":"2024-05-10","current":-35.176138,"twenty":-69.778748,"median":-59.371617,"eighty":-52.278619,"marketCap":2000537303},{"date":"2024-05-17","current":-36.289307,"twenty":-68.393255,"median":-58.232975,"eighty":-49.860318,"marketCap":2063845445},{"date":"2024-05-24","current":-35.140985,"twenty":-67.52163,"median":-57.330453,"eighty":-49.032283,"marketCap":1998538098},{"date":"2024-05-31","current":-40.179539,"twenty":-67.228921,"median":-56.207672,"eighty":-47.173317,"marketCap":2285090743},{"date":"2024-06-07","current":-40.894311,"twenty":-66.477632,"median":-55.878652,"eighty":-42.192617,"marketCap":2325741235},{"date":"2024-06-14","current":-40.788853,"twenty":-65.885708,"median":-55.522213,"eighty":-41.278647,"marketCap":2319743621},{"date":"2024-06-21","current":-37.625109,"twenty":-65.85969,"median":-54.631116,"eighty":-40.788853,"marketCap":2139815216},{"date":"2024-06-28","current":-35.445642,"twenty":-65.443392,"median":-54.494024,"eighty":-40.683395,"marketCap":2015864537},{"date":"2024-07-05","current":-36.125261,"twenty":-64.796178,"median":-54.151294,"eighty":-39.560851,"marketCap":2054515824},{"date":"2024-07-12","current":-40.378738,"twenty":-64.675841,"median":-53.136814,"eighty":-38.206301,"marketCap":2296419569},{"date":"2024-07-15","current":-41.491907,"twenty":-64.64657,"median":-52.780375,"eighty":-38.236766,"marketCap":2359727711},{"date":"2024-08-02","current":-39.652248,"twenty":-64.6173,"median":-52.752957,"eighty":-38.267232,"marketCap":2255102676},{"date":"2024-08-09","current":-38.949194,"twenty":-63.924553,"median":-51.752186,"eighty":-38.000071,"marketCap":2215118586},{"date":"2024-08-16","current":-40.572681,"twenty":-63.472479,"median":-49.956283,"eighty":-38.105529,"marketCap":2307449488},{"date":"2024-08-23","current":-42.377221,"twenty":-62.965116,"median":-49.723226,"eighty":-38.189896,"marketCap":2410077328},{"date":"2024-08-30","current":-43.2618,"twenty":-62.33047,"median":-48.934948,"eighty":-38.276606,"marketCap":2460385093},{"date":"2024-09-06","current":-44.299706,"twenty":-62.063778,"median":-48.270052,"eighty":-38.375033,"marketCap":2519412871},{"date":"2024-09-13","current":-41.079839,"twenty":-61.869081,"median":-45.980618,"eighty":-38.588613,"marketCap":2336292606},{"date":"2024-09-20","current":-46.127835,"twenty":-61.368222,"median":-44.806865,"eighty":-38.861791,"marketCap":2623382252},{"date":"2024-09-27","current":-43.379744,"twenty":-60.747027,"median":-44.736098,"eighty":-39.046612,"marketCap":2467092795},{"date":"2024-10-04","current":-42.412604,"twenty":-60.551887,"median":-44.517902,"eighty":-39.324835,"marketCap":2412089639},{"date":"2024-10-11","current":-40.667036,"twenty":-60.382766,"median":-44.458898,"eighty":-39.52313,"marketCap":2312815649},{"date":"2024-10-18","current":-43.356155,"twenty":-60.203473,"median":-44.063818,"eighty":-39.574912,"marketCap":2465751255},{"date":"2024-10-25","current":-42.990529,"twenty":-60.177247,"median":-43.698192,"eighty":-39.657154,"marketCap":2444957379},{"date":"2024-10-31","current":-42.837202,"twenty":-60.01213,"median":-43.662809,"eighty":-39.673778,"marketCap":2436237366},{"date":"2024-11-08","current":-46.068863,"twenty":-59.381569,"median":-43.651015,"eighty":-39.804577,"marketCap":2620028401},{"date":"2024-11-15","current":-32.980568,"twenty":-59.208121,"median":-43.63922,"eighty":-39.654701,"marketCap":2400853462},{"date":"2024-11-22","current":-30.044833,"twenty":-58.542987,"median":-43.538968,"eighty":-38.997903,"marketCap":2187143689},{"date":"2024-11-29","current":-32.283796,"twenty":-58.232975,"median":-43.444613,"eighty":-38.328163,"marketCap":2350131206},{"date":"2024-12-06","current":-31.17825,"twenty":-58.005312,"median":-43.379744,"eighty":-38.000071,"marketCap":2269651893},{"date":"2024-12-13","current":-26.821099,"twenty":-57.745125,"median":-43.279491,"eighty":-37.543086,"marketCap":1952468717},{"date":"2024-12-20","current":-26.031423,"twenty":-56.915781,"median":-43.120267,"eighty":-36.394765,"marketCap":1894983493},{"date":"2024-12-27","current":-27.044066,"twenty":-56.349294,"median":-43.061296,"eighty":-36.125261,"marketCap":1968699839},{"date":"2025-01-03","current":-26.914002,"twenty":-56.207672,"median":-43.037707,"eighty":-35.33784,"marketCap":1959231684},{"date":"2025-01-10","current":-28.298257,"twenty":-56.136384,"median":-42.978735,"eighty":-34.953504,"marketCap":2059999900},{"date":"2025-01-17","current":-27.034776,"twenty":-55.969133,"median":-42.872585,"eighty":-33.374909,"marketCap":1968023542},{"date":"2025-01-24","current":-32.158189,"twenty":-55.840266,"median":-42.689773,"eighty":-32.852839,"marketCap":2340987506},{"date":"2025-01-31","current":-31.530712,"twenty":-55.653821,"median":-42.565931,"eighty":-32.283796,"marketCap":2295309701},{"date":"2025-02-07","current":-31.405216,"twenty":-55.437216,"median":-42.394913,"eighty":-32.036945,"marketCap":2286174140},{"date":"2025-02-14","current":-29.805151,"twenty":-55.004006,"median":-42.206678,"eighty":-31.677123,"marketCap":2169695737},{"date":"2025-02-21","current":-29.512328,"twenty":-54.631116,"median":-41.999801,"eighty":-31.530712,"marketCap":2148379428},{"date":"2025-02-28","current":-25.768383,"twenty":-54.494024,"median":-41.775708,"eighty":-31.373843,"marketCap":1875835192},{"date":"2025-03-07","current":-28.226,"twenty":-54.39406,"median":-41.609082,"eighty":-31.094637,"marketCap":2054739928},{"date":"2025-03-14","current":-27.138374,"twenty":-54.151294,"median":-41.292708,"eighty":-30.560445,"marketCap":1975565066},{"date":"2025-03-21","current":-29.020804,"twenty":-53.671473,"median":-41.068045,"eighty":-30.21301,"marketCap":2112598481},{"date":"2025-03-28","current":-28.173711,"twenty":-53.493253,"median":-40.922206,"eighty":-29.826066,"marketCap":2050933444},{"date":"2025-04-04","current":-16.223536,"twenty":-52.780375,"median":-40.788853,"eighty":-29.478125,"marketCap":1428303862},{"date":"2025-04-11","current":-15.26259,"twenty":-52.725539,"median":-40.592885,"eighty":-29.073094,"marketCap":1343703153},{"date":"2025-04-17","current":-17.504797,"twenty":-52.648767,"median":-40.36956,"eighty":-28.807616,"marketCap":1541104808},{"date":"2025-04-25","current":-18.630229,"twenty":-51.927664,"median":-39.710836,"eighty":-28.715432,"marketCap":1640186719},{"date":"2025-05-02","current":-24.014988,"twenty":-51.631545,"median":-39.587801,"eighty":-28.276198,"marketCap":2114255557},{"date":"2025-05-09","current":-20.891121,"twenty":-50.318205,"median":-39.192738,"eighty":-28.046644,"marketCap":1839233409},{"date":"2025-05-16","current":-18.305859,"twenty":-49.931606,"median":-38.624431,"eighty":-27.822323,"marketCap":1932311557},{"date":"2025-05-23","current":-18.60193,"twenty":-49.805481,"median":-38.19927,"eighty":-27.481395,"marketCap":1963563934},{"date":"2025-05-30","current":-18.941329,"twenty":-49.745161,"median":-38.000071,"eighty":-27.137812,"marketCap":1999389828},{"date":"2025-06-06","current":-19.230179,"twenty":-49.665648,"median":-37.795014,"eighty":-26.986466,"marketCap":2029879952},{"date":"2025-06-13","current":-19.136302,"twenty":-49.503879,"median":-37.543086,"eighty":-26.644583,"marketCap":2019970662},{"date":"2025-06-20","current":-18.977435,"twenty":-49.032283,"median":-37.168124,"eighty":-26.449487,"marketCap":2003201094}],"updateTime":1750660305999}}}